Trial · NCT03100058
Participant flow78
How many started, completed or left each group, period by period.
41 to 60 of 78
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 10mg qd (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 50mg qd (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 150mg qd (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 2.5mg Bid (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 5mg Bid (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 25mg Bid (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 50mg Bid (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | Placebo (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 qd/LIK066 25 mg qd (Epoch 4) | 158 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | LIK066 Bid/LIK066 35 mg qd (Epoch 4) | 163 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | Placebo/LIK066 25 mg qd (Epoch 4) | 39 | |
| Epoch 4 (Last 24 Weeks of the Study) | STARTED | Placebo qd (Epoch 4) | 34 | |
| Epoch 4 (Last 24 Weeks of the Study) | COMPLETED | LIK066 2.5mg qd (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | COMPLETED | LIK066 10mg qd (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | COMPLETED | LIK066 50mg qd (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | COMPLETED | LIK066 150mg qd (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | COMPLETED | LIK066 2.5mg Bid (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | COMPLETED | LIK066 5mg Bid (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | COMPLETED | LIK066 25mg Bid (Epoch 3) | 0 | |
| Epoch 4 (Last 24 Weeks of the Study) | COMPLETED | LIK066 50mg Bid (Epoch 3) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03100058/flow?page=3